HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liangming Zhang Selected Research

Neoplasm Metastasis (Metastasis)

1/2024Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ERK axis in esophageal squamous carcinoma cancer.
1/2023Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
1/2021Computed Tomography‒Guided Microwave Ablation Combined with Osteoplasty for the Treatment of Bone Metastases: A Multicenter Clinical Study.
1/2019Anlotinib is effective in the treatment of advanced carcinoma ex pleomorphic adenoma of the submandibular gland.
3/2015A rare case of primary paranasal sinus angiosarcoma with pulmonary metastasis detected by 18F-FDG PET/CT.
1/2015EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liangming Zhang Research Topics

Disease

12Neoplasms (Cancer)
01/2024 - 06/2015
6Neoplasm Metastasis (Metastasis)
01/2024 - 01/2015
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2015
5Intervertebral Disc Displacement (Herniated Disc)
11/2023 - 01/2018
4Osteoporosis
03/2020 - 11/2010
3Lung Neoplasms (Lung Cancer)
01/2020 - 10/2018
2Anemia
12/2023 - 11/2021
2Adenocarcinoma of Lung
01/2022 - 01/2015
2Esophageal Squamous Cell Carcinoma
09/2021 - 01/2021
2Carcinoma (Carcinomatosis)
08/2021 - 01/2019
2Breast Neoplasms (Breast Cancer)
05/2021 - 06/2015
2Pathologic Constriction (Stenosis)
08/2020 - 01/2017
2Wounds and Injuries (Trauma)
04/2020 - 01/2018
1Epilepsy (Aura)
01/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024
1Adenocarcinoma
12/2023
1Parkinson Disease (Parkinson's Disease)
11/2023
1Down Syndrome (Down's Syndrome)
11/2023
1Alzheimer Disease (Alzheimer's Disease)
11/2023
1Endometrial Neoplasms (Endometrial Cancer)
01/2023
1Disease Progression
01/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022
1Spinal Cord Injuries (Spinal Cord Injury)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
12/2021
1Asthenia
11/2021
1Stomach Neoplasms (Stomach Cancer)
11/2021
1Alopecia (Baldness)
11/2021
1Colorectal Neoplasms (Colorectal Cancer)
07/2021
1Hypertrophy
01/2021
1COVID-19
10/2020
1Spinal Stenosis (Stenosis, Spinal)
08/2020
1Colonic Neoplasms (Colon Cancer)
01/2020
1Osteoarthritis
01/2020
1Dizziness (Lightheadedness)
01/2019
1Pleomorphic Adenoma
01/2019
1Vertigo (Positional Vertigo)
01/2019
1Cysts
01/2018
1Cough
01/2018
1Ossification of Posterior Longitudinal Ligament
06/2016
1Lordosis
06/2016
1Ascites
03/2016
1Malignant Pleural Effusion
03/2016

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2024 - 04/2014
4Biomarkers (Surrogate Marker)IBA
11/2023 - 06/2015
4AutoantibodiesIBA
12/2021 - 01/2020
3carbobenoxy- phenylalanyl- serine(O- benzyl)diazomethaneIBA
01/2024 - 01/2023
3AntigensIBA
01/2023 - 01/2020
3Immunoglobulin A (IgA)IBA
12/2021 - 01/2020
3Immunoglobulin G (IgG)IBA
12/2021 - 01/2020
2CystatinsIBA
01/2024 - 01/2023
2Cysteine Proteases (Cysteine Protease)IBA
01/2024 - 01/2023
2rezivertinibIBA
01/2023 - 01/2023
2Tumor Biomarkers (Tumor Markers)IBA
01/2023 - 09/2021
2MicroRNAs (MicroRNA)IBA
01/2022 - 04/2016
2human ERBB2 proteinIBA
11/2021 - 05/2021
2Bevacizumab (Avastin)FDA Link
07/2021 - 03/2016
2MelatoninIBA
01/2021 - 11/2010
2Phospholipases A2 (Phospholipase A2)IBA
07/2019 - 10/2018
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2015
2Gefitinib (Iressa)FDA Link
06/2015 - 01/2015
1Valproic Acid (Depakote)FDA LinkGeneric
01/2024
1Cytochrome P-450 CYP2C9IBA
01/2024
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2024
1sintilimabIBA
12/2023
1CrizotinibIBA
01/2023
1Rituximab (Mabthera)FDA Link
12/2022
1FucoseIBA
01/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2021
1squamous cell carcinoma-related antigenIBA
09/2021
1fascinIBA
08/2021
1XELOXIBA
07/2021
1Trastuzumab (Herceptin)FDA Link
05/2021
1CateninsIBA
01/2021
1Salivary CystatinsIBA
01/2021
1Viral RNAIBA
10/2020
1Vitamin DFDA LinkGeneric
03/2020
1Casein Kinase 1 epsilonIBA
01/2020
1Dinoprostone (PGE2)FDA Link
07/2019
1AcidsIBA
07/2019
1Messenger RNA (mRNA)IBA
07/2019
1anlotinibIBA
01/2019
1Anaplastic Lymphoma KinaseIBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1Therapeutic UsesIBA
01/2019
1CytokinesIBA
10/2018
1Phospholipases (Phospholipase)IBA
10/2018
1EnzymesIBA
10/2018
1Cisplatin (Platino)FDA LinkGeneric
03/2016

Therapy/Procedure

6Therapeutics
01/2024 - 06/2015
4Drug Therapy (Chemotherapy)
12/2023 - 11/2014
4Decompression
11/2023 - 01/2017
4Diskectomy (Discectomy)
01/2023 - 01/2018
2Aftercare (After-Treatment)
07/2019 - 01/2015
1Transplantation
01/2022
1Palliative Care (Palliative Therapy)
01/2021
1Reoperation
08/2020
1Punctures
01/2018
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2018
1Laminoplasty
06/2016
1Parenteral Infusions
03/2016